Pharmacokinetic Study of Single and Repeated Dose of Roflumilast 500 µg , in Healthy Chinese Subjects
Status:
Completed
Trial end date:
2011-09-01
Target enrollment:
Participant gender:
Summary
The primary objective is to assess the pharmacokinetics (PK) of roflumilast and its
metabolite roflumilast N-oxide after single and repeated oral administrations of roflumilast
500 μg in healthy Chinese subjects.